Cagrilintide (AM833) vs HCG (Human Chorionic Gonadotropin)
Updated November 4, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of Cagrilintide (AM833) and HCG (Human Chorionic Gonadotropin) (also searched as HCG (Human Chorionic Gonadotropin) vs Cagrilintide (AM833)) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
Cagrilintide (AM833) centers on metabolic, while HCG (Human Chorionic Gonadotropin) leans toward metabolic. On indexed research, HCG (Human Chorionic Gonadotropin) is ahead (Cagrilintide (AM833): 22 studies, Human clinical; HCG (Human Chorionic Gonadotropin): 57, Human clinical). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •Cagrilintide (AM833) is strongest for metabolic; HCG (Human Chorionic Gonadotropin) for metabolic.
- •Evidence: Cagrilintide (AM833) Human clinical (22 studies) vs HCG (Human Chorionic Gonadotropin) Human clinical (57).
- •Check the FDA-approval status chips above before assuming a legal use pathway.
Effect profiles, overlaid
At a glance
Amylin analog | Obesity and type 2 diabetes
LH Mimicry | Fertility support
Cagrilintide (AM833) vs HCG (Human Chorionic Gonadotropin): side-by-side
| Metric | Cagrilintide (AM833) | HCG (Human Chorionic Gonadotropin) |
|---|---|---|
| Class | Metabolic | Muscle |
| Regulatory status | FDA-approved | FDA-approved |
| Evidence grade | Human clinical | Human clinical |
| Studies indexed | 22 | 57 |
| Research level | FDA Approved | FDA Approved |
| Strongest effect | Metabolic & appetite | Metabolic & appetite |
| Healing & recovery | 1.0▲ | 1.0▲ |
| Muscle & body comp | 1.0▲ | 1.0▲ |
| Metabolic & appetite | 5.0▲ | 2.0 |
| Neuro & mood | 2.0▲ | 1.0 |
| Sleep & circadian | 1.0▲ | 0.0 |
| Inflammation & immune | 1.0▲ | 1.0▲ |
| Skin & aesthetics | 3.0▲ | 1.0 |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | Cagrilintide (AM833) | HCG (Human Chorionic Gonadotropin) |
|---|---|---|
| Mechanism | Long-acting amylin analog | LH receptor agonist |
| Route | Subcutaneous injection | Subcutaneous injection |
| Half-life | ~7–8 days | ~24 hours |
| Time to peak | — | 6 hours |
| Duration of action | Weekly dosing (investigational) | Varies |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is Cagrilintide (AM833)?
Cagrilintide (AM833) is a long-acting amylin analog investigated for once-weekly subcutaneous use in obesity and type 2 diabetes, most notably combined with semaglutide as CagriSema.
Full Cagrilintide (AM833) profile, mechanism & studies →What is HCG (Human Chorionic Gonadotropin)?
HCG (Human Chorionic Gonadotropin) is a glycoprotein hormone produced by the placenta during pregnancy, structurally similar to luteinizing hormone (LH). It plays a crucial role in regulating reproductive processes in both men and women. In clinical settings, HCG is primarily used to stimulate endogenous testosterone production in men with hypogonadism and to support fertility treatments in women, particularly in assisted reproductive technologies such as in vitro fertilization (IVF).
Full HCG (Human Chorionic Gonadotropin) profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | Even | Both ~1.0/5 |
| Muscle | Even | Both ~1.0/5 |
| Metabolic | Cagrilintide (AM833) | 5.0/5 effect signal |
| Neuro | Cagrilintide (AM833) | 2.0/5 effect signal |
| Sleep | Cagrilintide (AM833) | 1.0/5 effect signal |
| Inflammation | Even | Both ~1.0/5 |
| Skin | Cagrilintide (AM833) | 3.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack Cagrilintide (AM833) and HCG (Human Chorionic Gonadotropin)?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because at least one is a research-use compound, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
Cagrilintide (AM833) vs HCG (Human Chorionic Gonadotropin): side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
Cagrilintide (AM833) has 22 approved studies indexed (Human clinical), and HCG (Human Chorionic Gonadotropin) has 57 (Human clinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is Cagrilintide (AM833) or HCG (Human Chorionic Gonadotropin) better?
It depends on your goal. Cagrilintide (AM833) is strongest for metabolic; HCG (Human Chorionic Gonadotropin) for metabolic. HCG (Human Chorionic Gonadotropin) has more indexed studies (57). See the goal-by-goal breakdown above.
Is Cagrilintide (AM833) or HCG (Human Chorionic Gonadotropin) better for weight loss?
Cagrilintide (AM833) shows the stronger metabolic & appetite profile (5.0/5) in the AI-assigned effect profile — though weight-loss outcomes depend on the individual and the evidence base.
Is Cagrilintide (AM833) or HCG (Human Chorionic Gonadotropin) better for muscle?
Both land close on the muscle & body-composition axis.
Which has more research, Cagrilintide (AM833) or HCG (Human Chorionic Gonadotropin)?
Cagrilintide (AM833) has 22 approved studies indexed (Human clinical); HCG (Human Chorionic Gonadotropin) has 57 (Human clinical). Higher counts mean more to read, not proven superiority.
Can you stack Cagrilintide (AM833) and HCG (Human Chorionic Gonadotropin)?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of Cagrilintide (AM833) vs HCG (Human Chorionic Gonadotropin)?
Cagrilintide (AM833): no community-reported effects logged yet. HCG (Human Chorionic Gonadotropin): none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is Cagrilintide (AM833) or HCG (Human Chorionic Gonadotropin) FDA-approved?
Cagrilintide (AM833) is FDA-approved. HCG (Human Chorionic Gonadotropin) is FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is HCG (Human Chorionic Gonadotropin) better than Cagrilintide (AM833)?
For metabolic, HCG (Human Chorionic Gonadotropin) has the edge; for metabolic, Cagrilintide (AM833) does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
Approval status varies (see the chips at the top). FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed November 4, 2026.